Atlas Trials

Multi-national, Randomized, Phase III, GCIG Intergroup Study Comparing Pegylated Liposomal Doxorubicin (CAELYX) and Carboplatin vs. Paclitaxel and Carboplatin in Patients With Epithelial Ovarian Cancer in Late Relapse. (CALYPSO)

Clinical trial NCT00538603 · COMPLETED

Trial details

NCT number
NCT00538603
Sponsor
King Faisal Specialist Hospital & Research Center
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Epithelial Ovarian Cancer
Start date
2005-06-01
Primary completion
2013-06-01
Enrollment
8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.